tri, treatment research institute, asi, addiction severity index, mclellan, tom mclellan, thomas mclellan tri, treatment research, outcomes research, substance abuse treatment research tri, policy, drug policy, policy makers, national drug control policy tri, practice, clinical practice, treatment providers, drug treatment, substance abuse treatment, dens, treatment planning, asi, addiction severity index tri, for parents, parents, teens, teenagers, adolescents, teen drug use, asi, addiction severity index tri, training, tri training, asi training, dens training, treatment planning, asi, dens tri, asi, addiction severity index, mclellan, tom mclellan, thomas mclellan tri, resources, publications, presentations, instruments, manuals, links

PUBLICATIONS

From the Clinical Trials Network
Chapter and Reviews
McLellan AT. (2005) The status of the United States Treatment System: Implications for Evidence Based Treatments. In Miller, W. R., & Carroll, K. M. (Eds.) (in press). Rethinking substance abuse: What the science shows and what we should do about it. New York: Guilford Press.

Mercer, D, Woody, G.E. Individual psychotherapy and counseling for addiction. In: Oxford Textbook of Psychotherapy. Gabbard, G.O., Beck, J.S., Holmes, J. Oxford Univ. Press, Oxford, UK, 2005. Ch. 19, Pp. 237-245.

Woody, G.E. Review of "Clinical Manual of Dependence Psychopharmacology" by Kranzler, H.R., and Ciraulo, D.A. Am. J. Psychiatry, 163; 1:166, 2006.

Senay, E.C., Geller, A., Woody, G., M.Y.Abuse, dependence and misuse of prescription opioid analgesics, benzodiazepines and carisprodol in 7792 calls to poison control centers. CPDD meeting, Orlando, FL, 2005.

Smith, M.Y., Dart, R.C., Hughes, A., Geller, A., Senay, E., Woody, G. Clinician validation of poison control center calls involving abuse and misuse of prescription opioids. CPDD meeting, Orlando,FL, 2005.

Forman, R.F., McLellan, AT., Woody, G.E. No prescription websites: opioid medications available without a prescription. CPDD meeting, Orlando, FL, 2005.

Carise, D., Camilleri, A., McLellan, AT., Woody, G. Changes in Oxycontin use among treatment seekers: data from the DENS study. CPDD meeting, Orlando,FL, 2005.

Woody, G.E., Poole, S., Forman, R.F., Carise, D. A comparison of buprenorphine/naloxone adolescent opiate subjects and the Drug Evaluation Network Study. CPDD meeting, Orlando,FL, 2005.

Ziedonis, D., Amass, L., Steinberg, M., Woody, G., Krejci, J., Ling, W., Predictors of outcome in the NIDA Clinical Trials Network randomized, multicenter trial of buprenorphine-naloxone versus clonidine for short-term medically supervised withdrawal. CPDD meeting, Orlando,FL, 2005.

Krupitsky, E.M., Zvartau, E.E., Lioznov, D.A., Tsoy, M.V., Egorova, V.Y., Zorina, Y.A., Belyaeva, T.V., Antonova, R.V., Brazhenko, N.Z., Zagdyn, Z.M. Woody, G.E. Comorbidity of addictions, alcoholism and infectious diseases in St. Petersburg, Russia. CPDD meeting, Orlando,FL, 2005.

tri, asi, addiction severity index, mclellan, tom mclellan, thomas mclellan
tri, asi, addiction severity index, tsr, treatment services review, asi in spanish
tri, publications
tri, presentations
tri, archives, old stories, past features
tri, training, tri training, asi training, dens training, asi, dens, treatment planning, caspar
tri, register with tri, newsletter
tri, comments, feedback, contact us